Previous Article | Next Article 
Molecular and Cellular Biology, August 2000, p. 6074-6083, Vol. 20, No. 16
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Rap2 as a Slowly Responding Molecular Switch in
the Rap1 Signaling Cascade
Yusuke
Ohba,1,2
Naoki
Mochizuki,1
Keiko
Matsuo,1
Shigeko
Yamashita,1
Mie
Nakaya,1
Yuko
Hashimoto,3
Michinari
Hamaguchi,4
Takeshi
Kurata,3
Kazuo
Nagashima,2 and
Michiyuki
Matsuda1,*
Department of Pathology, Research Institute,
International Medical Center of Japan, Shinjuku-ku, Tokyo
162-8655,1 Department of Pathology,
National Institute of Infectious Diseases, Shinjuku-ku, Tokyo
162-8640,3 Department of Molecular
Pathogenesis, Nagoya University School of Medicine, Nagoya
466-8550,4 and Laboratory of
Molecular and Cellular Pathology, Hokkaido University School of
Medicine, Sapporo 060-8638,2 Japan
Received 29 December 1999/Returned for modification 8 February
2000/Accepted 8 May 2000
 |
ABSTRACT |
Rap2 is a member of the Ras family of GTPases and exhibits 60%
identity to Rap1, but the function and regulation of Rap2 remain obscure. We found that, unlike the other Ras family proteins, the
GTP-bound active form exceeded 50% of total Rap2 protein in adherent
cells. Guanine nucleotide exchange factors (GEFs) for Rap1, C3G, Epac
(or cyclic AMP [cAMP]-GEF), CalDAG-GEFI, PDZ-GEF1, and GFR
efficiently increased the level of GTP-Rap2 both in 293T cells and in
vitro. GTPase-activating proteins (GAPs) for Rap1, rap1GAPII and SPA-1,
stimulated Rap2 GTPase, but with low efficiency. The half-life of
GTP-Rap2 was significantly longer than that of GTP-Rap1 in 293T cells,
indicating that low sensitivity to GAPs caused a high GTP/GDP ratio on
Rap2. Rap2 bound to the Ras-binding domain of Raf and inhibited
Ras-dependent activation of Elk1 transcription factor, as did Rap1. The
level of GTP-Rap2 in rat 3Y1 fibroblasts was decreased by the
expression of v-Src, and expression of a GTPase-deficient Rap2 mutant
inhibited v-Src-dependent transformation of 3Y1 cells. Altogether, Rap2
is regulated by a similar set of GEFs and GAPs as Rap1 and functions as
a slowly responding molecular switch in the Rap1 signaling cascade.
 |
INTRODUCTION |
The Ras family of G proteins
consists of Ras (H-, N-, and K-), Rap1, Rap2, R-Ras, TC21, Ral, Rheb,
and M-Ras (R-Ras3) (5). Compared to Ras, which has been
extensively studied as a pivotal protein in cell growth and
differentiation (4, 8), much less is known about the
other Ras-family G proteins. Rap1, which shares its effector
domain with Ras, antagonizes Ras in many aspects. Overexpression of
Rap1 suppresses Ras-induced transformation of NIH 3T3 cells
(30), Ras-induced c-fos activation
(47), and Ras-dependent inhibition of muscarinic
K+ channels (53). At least some of these effects
appear to be due to the suppression of Ras-induced activation of
Raf serine/threonine kinase and mitogenic
ERK/mitogen-activated protein kinase (ERK/MAPK) (10, 19). In
concordance with these findings, constitutive activation of Rap1
inhibits interleukin-2 (IL-2) gene production and causes T-cell anergy
(7), and inhibition of Rap1 by insulin or lysophosphatidic
acid stimulates Ras (40). However, Rap1 may activate the
MAPK cascade in different milieus. Rap1 activates ERK/MAPK via
the activation of B-Raf in neuronal cells (52, 54) and
induces DNA synthesis and oncogenic transformation of Swiss 3T3 cells
(1, 55).
Rap1 circulates between GTP-bound active and GDP-bound inactive
states. The activation is induced by guanine nucleotide exchange factors (GEFs); these include C3G, CalDAG-GEFI, and Epac (or cyclic AMP
[cAMP]-GEF), which are activated by tyrosine kinases, Ca and diacylglycerol, and cAMP, respectively (12, 27, 28, 50). Thus, many signals converge at Rap1 via different GEFs. There are four
GTPase-activating proteins (GAPs) of Rap1: rap1GAP, SPA-1, GAP1IP48P, and tuberin (6). Little is
known about the regulation of these GAPs, except for that of an isoform
of rap1GAP, rap1GAPII, which has recently been shown to bind to and
transduce signal from the
subunit of heterotrimeric Gi
protein (37).
Knowledge about Rap2, the amino acid sequence of which shares 60%
identity with Rap1, is limited. Rap2 is reported to localize mainly in
the endoplasmic reticulum (ER), whereas Rap1 localizes at the Golgi
apparatus (2, 3). Unlike Rap1, Rap2 cannot reverse
Ras-induced transformation of NIH 3T3 cells (23), and no
biological phenotype has been linked to Rap2 in the literature. The
regulation of Rap2 also remains unknown. rap1GAP stimulates Rap2 GTPase
activity in vitro, albeit significantly more weakly than Rap1
(22). An attempt to purify a GAP specific to Rap2 culminated
in the isolation of rap1GAP (22). Very recently, de Rooij et
al. reported that a newly isolated GEF for Rap1, PDZ-GEF1, also
activates Rap2 and that GTP-bound Rap2 makes up more than 50% of the
Rap2 in A14 and COS1 cells (11).
Rap2 shares most of the effector proteins with Ras and Rap1, except for
a recently identified RPIP8 (21, 38), suggesting that there
is cross-talk among these three proteins. Here, we show that GEFs and
GAPs are shared between Rap1 and Rap2 and that, unlike the other Ras
family proteins, the GTP-bound active form makes up at least 50% of
Rap2 in adherent cells due to a low sensitivity to GAPs.
 |
MATERIALS AND METHODS |
Plasmids.
The cDNA fragment of Rap2A was amplified from a
human spleen cDNA library by PCR with primers
5'-CCCTCGAGATGCGCGAGTACAAAGTGGTG-3' and
5'-TTGCGGCCGCCTATTGTATGTTACATGCAGAACA-3'. A constitutively active mutant of Rap2 was designed by analogy to Ras: Gly 12 was substituted for by Val in Rap2V12 by PCR-mediated mutagenesis. Wild-type Rap1A (Krev1) and a constitutively active mutant, Rap1V12, were obtained from M. Noda (Kyoto University, Kyoto, Japan)
(30). pCEV-c-Ha-ras and pCEV-c-Ha-ras V12 were obtained from
K. Kaibuchi (NAIST, Nara, Japan). The coding sequences of human
H-Ras, Rap1A, and Rap2A were subcloned into pEBG (49);
pCXN2-Flag (39); pCAGGS-EGFP, pCAGGS-ECFP, and pGBT9
(Clontech); and pGEX4T-3 (Amersham-Pharmacia Biotech). pCAGGS-EGFP and
pCAGGS-ECFP are derivatives of pCAGGS (39) and encode
enhanced green fluorescent protein (EGFP) and enhanced cyan fluorescent
protein (ECFP) (Clontech), respectively. Expression plasmids of the
wild type and a constitutively active mutant of c-Raf1, pSR
-Raf and
pSR
-SKR, respectively, were obtained from S. Hattori (NCNP, Tokyo,
Japan). The DNA fragment covering the Ras-binding domain (RBD) and
cysteine-rich domain (CRD) of c-Raf1 was amplified by PCR with primers
5'-CTCGAGCCTTCTAGACAAGCAACACT-3' and
3'-GCGGCCGCGACTCCACTATCACCAATAGT-5' and subcloned into
pGEX4T-3 and pGAD424 (Clontech) to generate pGEX-Raf-RBD+CRD
and pGAD424-Raf-RBD+CRD, respectively. pGEX-RalGDS-RBD and pmt2-sm-ha
Epac were obtained from J. L. Bos (Utrecht University) (12,
14). The entire coding region of Epac was amplified by PCR with
primers 5'-GTCGACATGGTGTTGAGAAGGATGCACCGG-3' and
3'-GCGGCCGCTCATGGCTCCAGCTCTCGGGAG-5'. The entire
coding region of mouse CalDAG-GEFI cDNA was amplified by PCR from
a mouse spleen cDNA library with primers
5'-GGTCGACATGGCGAGCACTCTGGACCTGGA-3' and
5'-AGTCACAGCGTCTTATAATTGGATG-3'. cDNAs of KIAA0277 (GFR)
and KIAA0313 (PDZ-GEF1) were provided by N. Nomura (Kazusa
Institute, Kisarazu, Japan). cDNAs of Epac, mouse CalDAG-GEFI, GFR, and
PDZ-GEF1 were subcloned into pCXN2-Flag and pGEX-4T3. pCXN2-rap1GAPII
has been described previously (37). The entire coding
region of rap1GAPII was subcloned into pAcSG2-His (Pharmingen) to
generate pAcSG2-His-rap1GAPII. pSR
-SPA-1 was obtained from N. Minato
(Kyoto University) (31). pYFP-ER and pYFP-Golgi were
purchased from Clontech.
Cell culture and transfection.
The cell lines used in this
study were 293T (obtained from B. J. Mayer, Harvard Medical
School), NIH 3T3 (JCRB 0615), HT1080 (ATCC CCL121), 3Y1 (JCRB 0734),
SR-3Y1 (26), HR-3Y1 (JCRB 0743), Crk-3Y1 (34),
NY72-3Y1, MDCK (ATCC CCL34), and Jurkat (ATCC TIB152). NY72-3Y1 cells
express a temperature-sensitive mutant of v-Src,
v-SrctsNY72-4 (36). Adherent cells were cultured
in Dulbecco's modified Eagle medium (MEM) (Nissui, Tokyo)
supplemented with 10% fetal calf serum (FCS). Jurkat cells were
cultured in RPMI 1640 (Nissui) with 10% FCS. Expression plasmids were
introduced into 293T cells by the calcium-phosphate precipitation
method, into NIH 3T3 cells with Superfect (Qiagen), and into MDCK cells
with FuGENE6 (Roche Molecular Biochemicals).
Cell lines expressing Rap2 and Rap1.
NY72-3Y1 cells were
transfected with pCXN2-Flag-Rap2WT, pCXN2-Flag-Rap2V12,
pCXN2-Flag-Rap1WT, pCXN2-Flag-Rap1V12, and pCAGGS and with a
hygromycin resistance gene, followed by selection in the medium
containing 200 µg of hygromycin B per ml at 40°C. After 10 days,
cells were transferred to an incubator maintained at 33°C for the
induction of the active v-Src and cultured further for 24 h. We
observed the morphology of the colonies under the microscope and scored
transformed and nontransformed colonies as described previously
(30).
Antibodies.
Anti-Rap2 monoclonal antibody, anti-Flag M2
monoclonal antibody, and anti-Rap1 polyclonal antibody were purchased
from Transduction Laboratories, Sigma, and Santa Cruz, respectively.
Anti-pan-Ras monoclonal antibody was supplied by S. Hirohashi
(24). Anti-rap1GAP and anti-C3G antibodies were developed in
our laboratory (37, 50). Horseradish peroxidase-conjugated
antiphosphotyrosine antibody, RC20, was purchased from Transduction Laboratories.
Preparation of GST-tagged proteins.
Recombinant proteins
fused to glutathione S-transferase (GST) were expressed in
Escherichia coli from pGEX-derived vectors and purified as
described previously (35).
Purification of rap1GAPII.
Recombinant baculovirus carrying
rap1GAPII cDNA was produced by the cotransfection of
pAcSG2-His-rap1GAPII and baculo-Gold DNA (Pharmingen) according to the
manufacturer's protocol. The recombinant baculovirus was inoculated
into Sf9 cells cultured in TC100 (Gibco BRL) containing 10% fetal
bovine serum. Forty-eight hours after infection, cells were suspended
in lysis buffer, disrupted by freeze-thawing, cleared by
centrifugation, and loaded onto a HiTrap chelating column
(Amersham-Pharmacia). After washing with 20 mM imidazole (pH 8.0)
containing 100 mM NaCl, His-tagged rap1GAPII was eluted in 200 mM
imidazole (pH 8.0) containing 100 mM NaCl and dialyzed against 20 mM
Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl2, and 1 mM
dithiothreitol (DTT).
Analysis of guanine nucleotides bound to Rap1 and Rap2.
Guanine nucleotides bound to Rap1 and Rap2 were analyzed essentially as
described previously (16). Briefly, 293T cells were transfected with pEBG-Rap1 or Rap2 with or without other expression plasmids. Twenty-four hours after transfection, cells were labeled for
2 to 4 h with 32Pi in phosphate-free MEM
(GibcoBRL). GST-tagged Rap1 and Rap2 were collected on
glutathione-Sepharose beads. In another experiment, 293T cells were
transfected with pCXN2-Flag-Rap1 or Rap2. After 32Pi labeling, Flag-tagged Rap1 and Rap2 were
immunoprecipitated with anti-Flag M2 monoclonal antibody and protein
G-Sepharose. Guanine nucleotides bound to Rap1 and Rap2 were separated
by thin-layer chromatography (TLC) and quantitated with a BAS-1000
image analyzer (Fuji-Film).
Analysis of the guanine nucleotide exchange and GTP hydrolysis in
vivo.
293T cells (2 × 105) transfected with
pEBG-Rap1 or pEBG-Rap2 were labeled with 2 MBq of
32Pi for 30 min in phosphate-free MEM and
chased with complete medium. At each time point, cells were lysed and
guanine nucleotides bound to G proteins were quantitated as described
above. We also measured the radiolabeling efficiency of the guanine
nucleotides as follows. The labeled 293T cells were freeze thawed in
800 µl of hypotonic buffer (10 mM Tris-HCl [pH 8.0], 1.5 mM
MgCl2, 10 mM KCl, 0.1 mM DTT) and clarified by
centrifugation at 10,000 × g for 15 min. Two hundred
microliters of the resulting supernatant was added to equal amounts of
2× exchange buffer (40 mM Tris [pH 8], 30 mM EDTA, 2 mM DTT). After
the addition of 1 µg of recombinant GST-H-Ras and incubation at
37°C for 10 min, the loading reaction was terminated by the addition
of MgCl2 at 20 mM. GST-H-Ras loaded with guanine
nucleotides was collected with glutathione-Sepharose, and the
32P-labeled guanine nucleotides were separated by TLC and
quantitated. We used recombinant GST-H-Ras because it showed the
highest in vitro loading efficiency among various G proteins tested by us.
Detection of GTP-bound Ras family G proteins.
Detection of
GTP-bound Ras-family G proteins was performed by the Bos method with
slight modifications (14). Briefly, cells were lysed in
lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 5 mM
MgCl2, 1% NP-40, 0.5% deoxycholic acid, 0.1% sodium
dodecyl sulfate [SDS], 1 mM Na3VO4),
clarified by centrifugation, and incubated with either GST-RalGDS-RBD
or GST-Raf-RBD+CRD prebound to glutathione-Sepharose beads for 1 h
at 4°C. Beads were washed twice with lysis buffer and resuspended in
SDS-sample buffer. Proteins bound to the beads were separated by
SDS-polyacrylamide gel electrophoresis (PAGE) and analyzed by
immunoblotting with either anti-Rap1 or anti-Rap2 antibodies. Bound
antibodies were detected by the ECL enhanced chemiluminescence system
(Amersham Pharmacia) and analyzed with an LAS-1000 image analyzer
(Fuji-Film). In another experiment, 293T cells were transfected with
pCXN2-Flag-derived vectors encoding Rap2, Rap1, and H-Ras or with
pCXN2-Flag-rap1GAPII. After 24 h, cells were lysed in lysis buffer
and processed as described previously, except that anti-Flag M2
antibody was used for detection of the recombinant G proteins.
In vitro binding of Rap2 to Raf and RalGDS.
GST-Rap2 was
cleaved with thrombin. After the removal of GST with
glutathione-Sepharose, 2.5 µg of Rap2 was loaded with either 0.5 mM
GTP or 0.5 mM GDP in exchange buffer (50 mM Tris-HCl [pH 7.5], 25 mM
EDTA, 0.5 mg of bovine serum albumin [BSA] per ml, 1 mM DTT) at
37°C for 20 min. The reaction was terminated by the addition of
MgCl2 at 50 mM. The nucleotide-bound Rap2 was incubated with 20 µg of GST, GST-Raf-RBD+CRD, or GST-RalGDS-RBD, prebound to
glutathione-Sepharose in binding buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM MgCl2, 25 µM ZnCl2, 1 mM DTT, 0.2% BSA, 1% Triton X-100) for 1 h at 4°C. After extensive washing with binding buffer, proteins applied or bound to the beads were analyzed by
immunoblotting with anti-Rap2 antibody.
Guanine nucleotide exchange reaction in vitro.
A fluorescent
analogue of GDP, 2',
3'-bis(O)-(N-methylanthranolol)-GDP (mGDP), was
purchased from Dojin Kagaku (Kumamoto, Japan). GST-Rap2 and GST-Rap1
were loaded with mGDP as described previously (32). The mGDP
loading efficiency for Rap1A was between 80 and 90%, and for Rap2A, it
was between 40 and 50%. For the measurement of GEF activity, 400 nM
labeled Rap2A or Rap1A was incubated with or without 100 nM GEFs in
reaction buffer (50 mM Tris-HCl [pH 7.5], 5 mM MgCl2, 2 mM DTT) at 20°C. For activation of Epac, an analogue of cAMP,
Sp-adenosine 3',5'-cyclic monophothioate triethylamine salt (Sp-cAMPS,
Research Biochemical International), was included at 100 µM. The
reaction was started by addition of GTP at 200 µM. The decrease in
fluorescence was monitored in a JASCO FP-750 fluorescence spectrometer,
with excitation and emission wavelengths of 366 and 450 nm, respectively.
In vitro GAP assay.
Cells were washed in TBS (20 mM Tris
[pH 7.5], 150 mM NaCl, 1 mM Na3VO4) and
freeze-thawed in TBS-Mg (20 mM Tris [pH 7.5], 150 mM NaCl, 5 mM
MgCl2, 2 mM DTT, 1 mM Na3VO4).
After centrifugation at 10,000 × g for 15 min,
supernatants were used as a crude cytosolic fraction. GAP activity was
measured in vitro as described previously (18). GST-Rap1A or
GST-Rap2A (5 µM each) was loaded with [
-32P]GTP in
loading buffer (20 mM Tris [pH 8], 1.5 µM GTP, 10 mM 2-mercaptoethanol, 5 mM MgCl2, 20 mM EDTA, 10% glycerol,
0.5 mg of BSA per ml) at 30°C for 15 min, followed by the addition of MgCl2 to 20 mM. Purified rap1GAPII or crude cell lysates
were added to 250 nM GST-Rap1A or GST-Rap2A in reaction buffer (20 mM
Tris, 5 mM MgCl2, 0.5 mg of BSA per ml) at 30°C. The
reaction was terminated by addition of ice-cold washing buffer (20 mM
Tris-HCl [pH 8], 5 mM MgCl2, 100 mM NaCl). Samples were
adsorbed to nitrocellulose filters (S&S). The filters were washed three
times with washing buffer, dried, and analyzed with a BAS-1000 image analyzer.
Fluorescence microscopy.
HT1080 cells grown on
fibronectin-coated coverslips were fixed with 90% ethanol.
Alternatively, cells were fixed with 4% paraformaldehyde in
phosphate-buffered saline (PBS) and permeabilized with 0.2% Triton
X-100 in PBS for 5 min. Cells were preincubated in PBS containing 1%
BSA for 30 min and incubated with anti-Rap2 monoclonal antibody or
anti-Rap2 preadsorbed to GST-Rap2, followed by incubation with Alexa
488 goat anti-mouse antibody (Molecular Probes, Leiden, The
Netherlands). 293T and MDCK cells were transfected with
pCAGGS-EGFP-Rap2, pCAGGS-EGFP-Rap1, or pCAGGS-EGFP-H-Ras and observed
with an LSM-510 confocal microscope (Carl Zeiss). In other experiments,
MDCK cells were cotransfected with pCAGGS-ECFP-Rap2 and pYFP-ER or
pYFP-Golgi and observed with the confocal microscope.
Immunoelectron microscopy.
Immunoelectron microscopy was
performed essentially as described previously (46). HT1080
cells were harvested with a cell scraper, fixed in 0.1 M phosphate
buffer (pH 7.4) containing 3% paraformaldehyde and 0.05%
glutaraldehyde for 1 h at room temperature, dehydrated in ethanol,
and embedded in Lowicryl K4M (Polysciences, Inc., Eppelheim, Germany)
at
40°C for 24 h. After UV polymerization, blocks were trimmed
and mounted in the microtome. Sections were collected on uncoated
nickel grids, preincubated in PBS containing 1% BSA for 10 min at room
temperature, and incubated in the same buffer containing anti-Rap2
monoclonal antibody overnight at 4°C. After being washed in PBS, the
sections were further incubated with goat anti-mouse antibody
conjugated with 10-nm-diameter colloidal gold (British Biocell,
Cardiff, Wales) followed by counterstaining with 1% osmium tetroxide
and with 2% uranyl acetate and Millonig's lead acetate. Sections were
examined under a JEOL JEM-1200-EX transmission electron microscope.
Yeast two-hybrid analysis.
Yeast strain y-190 was double
transformed with pGBT9-derived vectors and pGAD424-derived vectors.
Transformants were grown on plates containing y-NB-Ura-Leu-Trp. Grown
colonies were transferred to nitrocellulose filters and examined for
-galactosidase activity.
Reporter assay.
Activation of the Elk1 transcription factor
was assayed by use of a PathDetect kit (Stratagene). Briefly, 2 × 105 293T cells were transfected with 1 µg of pFR-Luc
reporter plasmid, 0.1 µg of pFA-Elk1 encoding the activator domain of
the Elk1 transcription factor, 0.5 µg of pCMV-
gal, and 0.5 to 1 µg of test plasmids. After 24 h, cells were lysed in lysis
buffer, and luciferase activity was measured with the Promega
Luciferase Assay System. The activity of
-galactosidase was measured
for normalization of the transfection efficiency.
 |
RESULTS |
High GTP/GDP ratio on Rap2.
As an initial characterization of
Rap2, the GTP/GDP ratio on Rap2 was determined. We labeled NIH 3T3
cells and 293T cells expressing either Flag- or GST-tagged Rap2 protein
with 32Pi and quantitated by TLC the guanine
nucleotides bound to Rap2 (Fig. 1A). In
contrast to Rap1, 5 to 19% of which existed as GTP-bound form in
repeated experiments, between 50 and 70% of the labeled Rap2 protein
was in the GTP-bound form. Both the Flag and GST tags yielded similar
results. However, it was still possible that the high GTP/GDP ratio on
Rap2 might result from tagging of the proteins at the N terminus. Thus,
we examined the effect of the overexpression of GEFs for Rap1, which,
as we shall describe later, also promote the guanine nucleotide
exchange of Rap2. The endogenous GTP-bound Rap2 was recovered from the
cell lysates by the use of GST-RalGDS and quantitated by the Bos method
(14). As shown in Fig. 1B, the increase in GTP-bound Rap2
did not exceed 30% of the control level after the expression of C3G,
CalDAG-GEFI, or Epac/cAMP-GEFI. In contrast, expression of these GEFs
increased GTP-bound Rap1 from four- to sevenfold. The transfection
efficiency exceeded at least 50% when it was monitored with the GFP
expression vector. Thus, this result supports the idea that the basal
level of endogenous GTP-Rap2 was already high before the overexpression of GEFs.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 1.
Analysis of guanine nucleotides bound to Rap2. (A) 293T
cells or NIH 3T3 cells were transfected with expression vectors
encoding the proteins listed at the top and labeled with
32Pi. Guanine nucleotides bound to the
expressed Rap1 or Rap2 were separated by TLC. The radioactivity of GTP
and GDP was quantitated, and the percentage of GTP [GTP/(GDP + GTP)] is shown at the bottom. (B) 293T cells were transfected with
Flag-tagged expression vectors as indicated at the top. In one sample,
cells were incubated with 100 µM Sp-cAMPs for 10 min before harvest
(indicated as cAMP). Endogenous GTP-Rap2 and GTP-Rap1 were detected by
the Bos method as described in the text (top). The intensity of the
bands was quantitated by an image analyzer, and the fold increase is
shown. The lower panels show immunoblotting (IB) of total cell lysates
with anti-Rap2, anti-Rap1, or anti-Flag antibody.
|
|
GEFs for Rap2.
To understand the mechanism by which Rap2
retains a high GTP/GDP ratio, we examined whether GEFs for Rap1 also
stimulated guanine nucleotide exchange of Rap2. 293T cells expressing
GEFs were labeled with 32Pi, and the guanine
nucleotides bound to Rap1 or Rap2 were quantitated by TLC (Fig.
2A). The amount of GTP-bound Rap2 was
increased by the coexpression of GEFs for Rap1. Epac/cAMP-GEFI in the
presence of cAMP analog and PDZ-GEF1 showed the highest activity,
followed by GFR, CalDAG-GEFI, and C3G. mSos, Ras-GRF, and Ras-GRP did
not increase the amount of GTP-bound Rap2 (Y. Ohba and M. Matsuda, unpublished data).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 2.
GEF-dependent guanine nucleotide exchange reaction of
Rap2. (A) 293T cells expressing GST-Rap2 or GST-Rap1 with GEFs
indicated at the top were labeled with 32Pi,
and guanine nucleotides bound to GST-Rap2 or GST-Rap1 were analyzed as
described. In four samples, cells were incubated with 100 µM Sp-cAMPS
for 10 min before harvest (indicated as cAMP). (B) Rap1 or Rap2 bound
to mGDP was incubated at 20°C with or without GEFs. Epac was
stimulated with 100 µM Sp-cAMPS (indicated as cAMP). The decrease in
fluorescence emission at 450 nm was monitored as a function of time.
|
|
The guanine nucleotide exchange of Rap2 was examined in vitro in the
presence of GEFs for Rap1. A fluorescent analogue of
guanine
nucleotide, mGDP, was loaded on Rap1 or Rap2, and dissociation
was
monitored by a fluorescence spectrometer in the presence of
GEFs as
described previously (
32). Epac/cAMP-GEFI in the presence
of
cAMP showed the highest activity toward Rap2, followed by CalDAG-GEFI
(Fig.
2B). Because full-length C3G did not show significant activity
in
vitro, we used only its catalytic domain, called C3G-CD, for
this
study. C3G-CD did not show any detectable activity toward
Rap2 in
vitro, as described previously (
51). However, the activity
of C3G-CD toward Rap1 was significantly weaker than that of CalDAG-GEFI
and Epac/cAMP-GEFI, probably due to the lack of a Ras-exchange
motif;
therefore, this observation does not necessarily exclude
C3G from GEFs
for
Rap2.
Guanine nucleotide exchange rate in the cells.
Because the
GTP/GDP ratio on Ras family G proteins is determined primarily by GEFs
and GAPs, the high GTP/GDP ratio on Rap2 may occur because of either a
high guanine nucleotide exchange rate or low GTPase activity in the
cells. We first analyzed the turnover rate of guanine nucleotides on
Rap1 and Rap2 in the cells. For this purpose, cells were labeled with
32Pi for 30 min and chased up to 3 h. The
labeling efficiency of the cytosolic guanine nucleotides and the
radioactivity of the 32Pi-labeled guanine
nucleotides on Rap2 and Rap1 were quantitated at each time point and
plotted (Fig. 3A). Because cytosolic
32P-labeled guanine nucleotides decreased faster than
32P-labeled guanine nucleotides bound to Rap1 or Rap2, the
guanine nucleotide exchange reaction, but not the synthesis of the
guanine nucleotides, was the limiting step in the loading of the
radiolabeled guanine nucleotides to Rap1 or Rap2. In this condition,
the levels of radiolabeled guanine nucleotides on Rap1 and Rap2
decreased with a similar time course. Thus, the velocity of the guanine nucleotide exchange reaction does not account for the high GTP/GDP ratio on Rap2. When we plotted the percentage of GTP on Rap1 or Rap2,
we found that GTP bound to Rap2 decreased remarkably slower than GTP
bound to Rap1 (Fig. 3B). This result demonstrates that low GTPase
activity of Rap2 is the principal cause of the high GTP/GDP ratio in
the cells.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Guanine nucleotide exchange and GTP hydrolysis of Rap1
and Rap2 in vivo. 293T cells were labeled with
32Pi for 30 min and chased with
phosphate-containing medium. Cells were harvested at the indicated time
points, and the cytosolic fraction was used to load recombinant H-Ras
protein with 32P-labeled guanine nucleotides in vitro. The
cytosolic guanine nucleotides bound to H-Ras in vitro were separated by
TLC and quantitated. In a parallel experiment, 293T cells expressing
GST-Rap1 or GST-Rap2 were lysed, and the labeled guanine nucleotides
bound to GST-Rap1 or GST-Rap2 were separated by TLC and quantitated.
(A) The sum of radioactivity of GTP and GDP at each time point was
plotted at a ratio to the radioactivity at 30 min. (B) The percentage
of GTP on GST-Rap2 or GST-Rap1 at each time point was plotted. Bars
indicate standard deviations.
|
|
Stimulation of Rap2 GTPase by GAPs.
We next examined
whether GAPs for Rap1 stimulated Rap2 GTPase in the cells
(Fig. 4A). Both rap1GAPII and SPA-1
stimulated Rap2 GTPase, albeit less efficiently than they did
Rap1. The sensitivity of Rap2 and Rap1 to rap1GAPII was further
compared in vitro (Fig. 4B). rap1GAPII stimulated GTPase activity
of both Rap1 and Rap2 in a dose- and time-dependent manner; however,
Rap1 was significantly more sensitive than Rap2. We next used the
cytosolic fractions of Jurkat, HT1080, and 293T cells as a source of
GAP, because the GAP activity of Rap1 and Rap2 exists mostly in the
cytosolic fraction (22). As shown in Fig. 4C, we could not
detect GAP activity toward Rap2 in the cytosolic fraction of the cells,
whereas, under the same conditions, Rap1 GTPase was stimulated.
These results support the proposal that the low GTPase activity of
Rap2 causes a high GTP/GDP ratio on Rap2.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Activation of Rap2 GTPase by GAPs. (A) 293T cells
expressing either GST-Rap2 or GST-Rap1 and GEFs and GAPs indicated at
the top were labeled with 32Pi, and guanine
nucleotides bound to GST-Rap1 or GST-Rap2 were separated by TLC. (B)
Rap1 and Rap2 were loaded with [ -32P]GTP and incubated
with the indicated amounts of rap1GAPII for 10 min (left panel).
Similarly, the 32P-labeled Rap1 and Rap2 were incubated
with (solid symbols) or without (open symbols) 1 µg of rap1GAPII for
the indicated periods (right panel). The radioactivity remaining on
Rap1 or Rap2 was quantitated and plotted. (C)
[ -32P]GTP-loaded Rap1 and Rap2 were incubated with
buffer alone, purified rap1GAPII, or cell lysates of Jurkat cells,
HT1080 cells, or 293T cells for 20 min. The radioactivity remaining on
Rap1 or Rap2 was quantitated and plotted. Bars indicate standard
errors.
|
|
Subcellular localization of Rap2.
For understanding the
function of Rap2, its subcellular localization was determined by
immunomicroscopy, GFP tagging, and immunoelectron microscopy. The
specificity of the anti-Rap2 antibody was examined by immunoblotting
(Fig. 5A). The Rap2 protein was detected
as a major protein at about 22 kDa both in HT1080 and in 293T cells,
although multiple faint bands were also detected in the
higher-molecular-mass range. Notably, only the 22-kDa band had
disappeared after preadsorption of the antibody to the recombinant Rap2. In addition, the proteins in the higher-molecular-mass range were
also detected when we omitted the primary antibody. This result
indicates that the anti-Rap2 antibody used in this study was specific
to Rap2 and that the proteins detected in the higher-molecular-mass region were due to nonspecific binding by the secondary antibody.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 5.
Subcellular localization of Rap2. (A) Total cell lysates
of HT1080 cells and 293T cells were separated by SDS-PAGE and
transferred to polyvinylidene difluoride membranes. Filters were
incubated with anti-Rap2 antibody, anti-Rap2 antibody preincubated with
GST-Rap2, or buffer alone. Filters were further incubated with a
peroxidase-conjugated antimouse antibody, which was detected by the ECL
enhanced chemiluminescence system. (B) HT1080 cells grown on
fibronectin-coated coverslips were fixed with paraformaldehyde and
permeabilized by Triton X-100 (PFA) or fixed with ethanol (EtOH). The
cells were incubated with anti-Rap2 antibody or anti-Rap2 antibody
preadsorbed by GST-Rap2. Bound antibodies are detected by the use of
antimouse Alexa 488-conjugated antibody. (C) 293T and MDCK cells grown
on poly-L-lysine-coated glass dishes were transfected with
expression vectors of EGFP-tagged Rap2, Rap1, and H-Ras for 24 h
and observed under a confocal microscope. (D) MDCK cells cultured on
poly-L-lysine-coated glass dishes were transfected with
expression vectors encoding ECFP-Rap2 and EYFP-ER or EYFP-Golgi for
24 h and observed with a confocal microscope. (E) HT1080 cells
were collected and embedded in Lowicryl. Ultrathin sections were
prepared and incubated with anti-Rap2 antibody or buffer alone ( ),
followed by incubation with antimouse antibody conjugated with
immunogold. Cells were arbitrarily divided into plasma membrane (PM),
ER, mitochondria (Mi), cytoplasm (Cy), and nucleus (Nu). Immunogold
particles in these regions were counted and plotted.
|
|
This anti-Rap2 antibody was applied to detection of Rap2 by indirect
immunofluorescent microscopy. HT1080 cells were fixed
with either
paraformaldehyde or ethanol, stained with the anti-Rap2
antibody, and
observed by confocal microscopy. Rap2 was detected
on the plasma
membrane and in the cytoplasm when we fixed the
cells with
paraformaldehyde, whereas Rap2 was detected mostly
in cells when cells
were fixed with ethanol (Fig.
5B). In both
cases, the signals were
markedly diminished when the antibody
was preincubated with GST-Rap2
(Fig.
5B) or when we neglected
the primary antibody (data not
shown).
The result described above allowed us to examine the localization of
Rap2 without using antibodies. We transfected 293T cells
and MDCK cells
with expression vectors encoding EGFP-tagged Rap2,
Rap1, and H-Ras and
observed the cells with a confocal laser microscope
(Fig.
5C). All of
H-Ras, Rap1, and Rap2 were enriched at the plasma
membrane, although
they were also detected in the cytoplasm. Because
Rap2 was reported to
localize at the ER (
3), localization of
Rap2 was compared
with the yellow fluorescent protein (YFP)-tagged
markers of the ER and
Golgi apparatus. As shown in Fig.
5D, only
a small portion of Rap2
colocalized with the ER and Golgi
apparatus.
Localization of endogenous Rap2 was further determined quantitatively
by immunoelectron microscopy. We detected immunogold
at various loci in
the HT1080 cells (data not shown). Cells were
divided arbitrarily into
five loci

the plasma membrane, ER mitochondria,
cytoplasm, and
nucleus

and the numbers of gold particles at these
loci were counted
(Fig.
5E). Specific binding was detected, mostly
to the plasma membrane
and to the cytoplasm. However, in the cells
embedded in Lowicryl, the
ER and Golgi apparatus were not clearly
discernible; therefore, signals
counted as "cytoplasm" should
include substantial amounts of
signals derived from the intracellular
membrane
compartments.
Binding of Rap2 to Raf and RalGDS.
Many of the Ras effector
proteins, including Raf and RalGDS, also bind to Rap1 (4).
We examined whether Rap2 also binds to Raf and RalGDS by using a yeast
two-hybrid assay and a pull-down assay. In the yeast two-hybrid assay,
both the wild-type and the constitutively active Rap2 associated with
the RBDs of Raf and RalGDS (Fig. 6A), as
did the wild-type and constitutively active Ras or Rap1. In the
pull-down assay, the active forms of Ras and Rap1 preferentially bound
to the RBDs of Raf and RalGDS. In contrast, both the wild-type and the
constitutively active form of Rap2 bound to the RBDs of Raf and RalGDS
with similar efficiency (Fig. 6B). To confirm the GTP dependency in the
binding of Rap2 to Raf and RalGDS, we performed an in vitro binding
assay. As shown in Fig. 6C, GTP-Rap2 bound to Raf and RalGDS. GDP-Rap2
did not bind to RalGDS; however, it bound to Raf-RBD+CRD, although less
efficiently than did GTP-Rap2. This weak binding may be ascribable to
the CRD, because the CRD of Raf binds to Ras and Rap1 in a
GTP-independent manner (19, 20). We further confirmed the
GTP-dependent binding in 293T cells expressing rap1GAPII. As shown in
Fig. 6D, the binding of Rap2 to Raf and RalGDS was significantly
reduced by the expression of rap1GAPII, indicating that Rap2 bound to
the effector in a GTP-dependent manner.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 6.
Binding of Rap2 to Raf and RalGDS. (A) Yeast strain
y-190 was cotransformed with the pGAD424-derived plasmids denoted at
the top and with the pGBT9-derived bait plasmids listed to the left.
His activity of the transformants was assayed on histidine-deficient
plates, followed by a -galactosidase assay. (B) 293T cells
expressing the Flag-tagged G proteins denoted at the top were lysed in
lysis buffer and incubated with GST alone, GST-Raf-RBD+CRD, or
GST-RalGDS-RBD. Proteins bound to these GST fusion proteins and the
total cell lysates were separated by SDS-PAGE and probed with anti-Flag
monoclonal antibody. (C) GST-Raf-RBD+CRD, GST-RalGDS-RBD, or GST alone
was incubated with buffer alone ( ) or recombinant Rap2 protein loaded
with GDP (D) or GTP (T). Proteins bound to the beads were separated by
SDS-PAGE and analyzed by immunoblotting (IB) with anti-Rap2 antibody.
(D) 293T cells expressing Flag-Rap2WT alone or Flag-Rap2WT and
rap1GAPII were harvested and incubated with GST-Raf-RBD+CRD or
GST-RalGDS-RBD. Proteins bound to the GST fusion proteins and total
cell lysates were analyzed by immunoblotting with anti-Flag antibody.
|
|
Rap2 inhibition of Ras-dependent transcriptional activity.
To
examine whether Rap2 interferes with Ras signaling, as does Rap1, we
monitored the Ras-dependent transcriptional activation of Elk1, which
is a direct downstream target of ERK/MAPK. As shown in Fig.
7, both the wild-type and constitutively
active Rap2 inhibited the Ras-dependent transcriptional activation of
Elk1, as did the constitutively active Rap1. In contrast, Elk1
activation by the constitutively active Raf was not abolished by the
expression of either form of Rap2. This result shows that
overexpression of Rap2 inhibits Ras-dependent Elk1 activation, probably
by inhibiting Raf activation, as does Rap1 (10, 19).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 7.
Inhibition of Ras-dependent transcription by Rap2. 293T
cells were transfected with pFR-luc, pFA-Elk1, and pCXN2-Flag-RasV12
(H-RasV12; solid columns) or pSR -SKR (Raf-SKR; shaded columns) in
combination with wild-type (WT) and active Rap2 or Rap1 expression
vectors. After 24 h, luciferase activity was measured. In this
assay system, expression of luciferase is driven by the Elk1
transcription factor. Mean values obtained from three experiments are
shown with standard errors.
|
|
Determination of the numbers of Rap2, Rap1, and Ras molecules in a
single cell.
If Rap2 antagonizes Ras signaling by competitive
binding to Ras effectors, the numbers of these Ras family molecules in
a cell must be critical in the physiologic milieu. Thus, we determined the quantity of Rap2, Rap1, and Ras by using recombinant Rap2, Rap1,
and H-Ras as standards (Fig. 8). Thirty
micrograms of proteins from 7.4 × 104 293T cells and
20 µg of proteins from 9.2 × 104 HT1080 cells were
applied to SDS-polyacrylamide gel and analyzed by immunoblotting. The
anti-Rap2 antibody used here recognizes both Rap2A and Rap2B.
Similarly, the anti-Rap1 antibody recognizes both Rap1A and Rap1B, and
anti-Ras antibody reacts with H-, K-, and N-Ras proteins. The
calculated numbers of Rap2, Rap1, and Ras molecules in a 293T cell were
4.6 × 106, 1.5 × 106, and 5.7 × 105, respectively; those in an HT1080 cell were 7.8 × 106, 1.1 × 106, and 5.6 × 105, respectively. Thus, Rap2 exceeds Ras and Rap1 in
number in 293T and HT1080 cells.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 8.
Quantitative immunoblotting (IB) of Ras, Rap1, and Rap2.
Thirty micrograms of proteins from 7.4 × 104 293T
cells and 20 µg of proteins from 9.2 × 104 HT1080
cells and recombinant Rap2, Rap1, or H-Ras, the amounts of which are
indicated at the bottom of each column, were separated by SDS-PAGE and
analyzed by immunoblotting with the antibodies indicated to the right.
With recombinant proteins used as a standard, the amounts of Rap2,
Rap1, and H-Ras in the cell lysates were determined and are shown at
the bottom of each lane of cell lysates.
|
|
Decreased level of GTP-Rap2 in transformed fibroblasts.
The
high basal level of GTP-Rap2 evoked the question of whether the level
of GTP on Rap2 varies under physiologic conditions. Because Rap2
antagonized Ras-dependent transcription, we speculated that the level
of GTP-Rap2 might be low in transformed cells. Compared to the level in
parental rat 3Y1 fibroblasts, the level of GTP-Rap2 was significantly
lower in three cell lines transformed by v-Src (SR-3Y1), v-Ras
(HR-3Y1), or v-Crk (Crk-3Y1) (Fig. 9A). To confirm that the level of GTP-Rap2 decreases by cellular
transformation, we used 3Y1 cells expressing a temperature-sensitive
mutant of v-Src, v-SrctsNY72-4 (Fig. 9B). The amount of
GTP-Rap2 in NY72-3Y1 cells at a permissive temperature, 33°C, was
similar to that in SR-3Y1 cells expressing wild-type v-Src. However, as
expected, the amount of GTP-Rap2 increased when NY72-3Y1 cells were
incubated at a nonpermissive temperature, 40°C.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 9.
Level of GTP-Rap2 in transformed cells. (A) 3Y1 cells
and 3Y1-derived transformed cells denoted at the top were lysed, and
500 µg each of the lysates was incubated with GST-RalGDS prebound to
glutathione-Sepharose beads. Proteins bound to the beads and 10 µg of
total cell lysates were analyzed by SDS-PAGE and immunoblotting with
anti-Rap2 antibody. (B) NY72-3Y1 cells and SR-3Y1 cells expressing a
temperature-sensitive mutant and wild-type v-Src, respectively, were
maintained at 33°C. After a temperature shift to 40°C, cells were
lysed at the times indicated and analyzed as in panel A. (C) Soluble
cytosolic fraction was prepared from NY72-3Y1 cell cultures at either
40 or 33°C. [ -32P]GTP-loaded Rap2 and Rap1 were
incubated with buffer alone, purified rap1GAPII, or 30 µg of the
soluble cytosolic fractions for 20 min. Radioactivity retained by Rap2
and Rap1 was quantitated and plotted. Bars indicated standard errors
from three samples. (D) Cell lysates used in panel C were separated by
SDS-PAGE and blotted with anti-rap1GAP (top). The levels of GTP-Rap2
and GTP-Rap1 in these cell lysates were analyzed as in panel A.
|
|
To understand the mechanism by which the level of GTP-Rap2 was
decreased in Src-transformed cells, we examined GAP activity
in the
lysates of NY72-3Y1 cells cultured at a permissive or nonpermissive
temperature. As shown in Fig.
9C, GAP activity in response to
Rap2 was
detected only in the lysates of cells maintained at permissive
temperature. Concordantly, we found that expression of rap1GAP
was
increased significantly in the cells cultured at the permissive
temperature (Fig.
9D). Thus, the expression level of rap1GAP appears
to
determine the level of GTP-Rap2.
Inhibition of Src transformation by Rap2.
Finally, we examined
whether GTPase-deficient Rap2 could inhibit morphological
transformation by v-Src. For this purpose, we introduced wild-type and
GTPase-deficient Rap1 or Rap2 into NY72-3Y1 cells and examined the
temperature-dependent transformation of the cells. We did not find a
remarkable difference in the morphology of the transfected cells at a
nonpermissive temperature (Fig. 10A).
However, at a permissive temperature, expression of Rap1 or Rap2
significantly inhibited the morphological transformation of NY72-3Y1
cells by v-Src. We counted the number of transformed or nontransformed
colonies at a permissive temperature and found that wild-type and
GTPase-deficient Rap2 inhibited transformation at similar levels
(Fig. 10B). Thus, the transformation can be blocked by high GTP-Rap2
levels.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 10.
Inhibition of morphological transformation by Rap2.
NY72-3Y1 cells were transfected with pCAGGS or pCAGGS-derived Flag-tag
expression vector for wild-type Rap2 (Rap2WT), Rap2V12, Rap1WT, or
Rap1V12 with an expression vector of the hygromycin resistance gene.
After selection with hygromycin B at 40°C for 10 days, cells were
cultured at 33°C overnight. (A) Morphology of the representative
colonies at 40 and 33°C. (B) Hygromycin-resistant colonies consisting
of transformed spindle cells or nontransformed flat cells were scored
under the microscope. Mean values obtained from two independent
experiments are shown with standard deviations. (C) Equal amounts of
cell lysates were analyzed by immunoblotting (IB) with anti-Flag
antibody.
|
|
 |
DISCUSSION |
The basal level of the GTP-bound form of the Ras family G proteins
is less than 20% in many cell types (14-16, 42, 48). This
low basal level of the GTP-bound form enables the Ras family G proteins
to transduce signals only when the proper stimuli activate GEFs
(29). We found that the basal GTP/GDP ratio of Rap2 is unexpectedly high and that this results from the low GTPase
activity of Rap2. The example closest to Rap2 may be RhoE, which does
not have detectable GTPase activity and remains mostly in the
GTP-bound form (13, 17). It has been proposed that RhoE acts
to inhibit signaling downstream of RhoA, altering some RhoA-regulated
responses (17). Rap2 may play a similar inhibitory role in
the Ras-signaling cascade for the following reason. First, previous
reports have demonstrated that the effector molecules are mostly shared
between Rap2 and Ras (21, 38), and we showed that the
wild-type Rap2 binds to Raf as efficiently as the GTPase-deficient
Rap2 mutant in the cells. Second, expression of Rap2 antagonized
Ras-dependent transcriptional activity, as did expression of Rap1.
Third, at least half of Rap2 localized at the plasma membrane, where
most of Ras localized. Fourth, the level of GTP-Rap2 decreased in a manner dependent on cellular transformation, in which Ras plays a
pivotal role. Finally, overexpression of Rap2 inhibited morphological transformation by v-Src.
Most GEFs for Rap1 that have been reported thus far,
Epac/cAMP-GEF, CalDAG-GEFI, PDZ-GEF1, and GFR, have been shown to
promote guanine nucleotide exchange of Rap2 in cells. Similar to GEFs, SPA-1 and rap1GAP activate Rap2 GTPase, although less efficiently than Rap1 GTPase. Moreover, most of the effectors are also shared between Rap1 and Rap2 (21, 38). This co-usage of GEFs, GAPs, and effectors between Rap1 and Rap2 implies that Rap1 and Rap2 function
in the same signaling cascade. The conspicuous difference, however, is
the low sensitivity of Rap2 to GAPs, which results in the long
half-life of the GTP-bound form and high GTP/GDP ratio in the cells.
These characteristics render the signaling from Rap2 to effectors weak
(less than twofold compared to the basal level) and prolonged, whereas
Rap1 transduces strong (several-fold) and transient signals. Thus, in
the Rap signaling cascade, Rap2 may determine the basal level, and Rap1
transduces signals rapidly and transiently in response to external stimuli.
It has been proposed that, unlike Ras, Rap1 and Rap2 are localized
mainly in the intracellular membrane compartments, such as the ER and
Golgi apparatus (2, 3). These previous studies utilized a
sucrose density gradient and indirect immunofluorescence for the
characterization. A low resolution of the sucrose density gradient
cannot exclude the localization of Rap1 and Rap2 in the plasma
membrane. In addition, as we showed in this study, fixatives significantly affect the staining pattern of Rap2 in indirect immunofluorescence. We used indirect immunofluorescence, GFP
tagging, and immunoelectron microscopy to determine the subcellular
localization of Rap2 and found that Rap2 is both at the plasma membrane
and in the intracellular compartments. This observation provides a basis for the Rap2 inhibition of Ras-induced Raf activation at the
plasma membrane.
A recent report demonstrated that sequences unique to each Ras family
protein preceding the CAAX box affect the efficiency of translocation
from the ER or Golgi apparatus to the plasma membrane (9),
providing a reason why the distribution of each Ras family G protein
differs in the cells. However, it is not well established whether this
difference in the C-terminal amino acid sequence plays a critical role
in the signaling from Ras, Rap1, and Rap2. A study using chimeras
between H-Ras and Rap1 demonstrated that the effector domain, but not
the carboxyl-terminal region including the CAAX box, determines the
antioncogenic activity of Rap1 (56). Moreover, recent
reports that B-Raf is activated by both Ras and Rap1 suggest that the
difference in the subcellular localizations of Ras and Rap1 may not be
critical in the activation of downstream effectors, such as B-Raf
(41, 52, 54). In contrast to these reports, Matsubara et al.
have shown that the localization of Rap1 overexpressed at the
perinuclear region causes its inability to activate Ral via RalGDS,
because Ral is localized mostly in the plasma membrane (33).
It is noteworthy that, in native cells, the site of GEF activation is
regulated. Although we demonstrated that Rap2 is localized both on the
plasma membrane and within the cells, the site of Rap2 activation by
GEFs remains unknown. A method to detect the GTP-bound Rap2 in the
cells is awaited to solve this question.
In several adherent cells tested, we could not detect any remarkable
increase or decrease in GTP-Rap2 upon various types of stimulation that
increase GTP-Rap1, such as serum, lysophosphatidic acid, and
12-O-tetradecanoylphorbol 13-acetate (TPA). Reedquist and
Bos reported that GTP-Rap2 increased rapidly when human T cells were
stimulated with TPA (44). Preliminary data in our laboratory
with Jurkat cells have suggested that the amount of GTP-Rap2 in Jurkat
cells is significantly lower than that in fibroblasts (Y. Ohba and M. Matsuda, unpublished data). These results may be interpreted as showing
that the GTP/GDP ratio on Rap2 is low in T cells. Recently, it has been
shown that Rap1 activates integrin (25, 45). Attachment of
fibroblasts to fibronectin-coated dishes induces a rapid and transient
increase in GTP-Rap1 (43). Thus, Rap1 may be required in the
initial step of cell adhesion, which is then maintained by GTP-Rap2.
This hypothesis is supported by our observation that the v-Src-induced
transformation was inhibited by the overexpression of Rap2, because a
hallmark of morphologic transformation of cells is loose attachment to
the substrate.
In conclusion, Rap2 and Rap1 share GEFs, GAPs, and effectors in common,
indicating that both are components of the same signaling cascade. The
difference in the sensitivity to GAPs suggests that, in this Rap
signaling cascade, Rap1 and Rap2 function as the fast and slow
molecular switches, respectively.
 |
ACKNOWLEDGMENTS |
We thank J. L. Bos, A. Wittinghofer, B. J. Mayer, C. Lenzen, S. Hattori, S. Hirohashi, S. Iwasaka, J. Miyazaki, H. Kitayama, and M. Noda for materials and K. Okuda, N. Otsuka, and F. Ohba for
technical assistance.
This work was supported by grants from the Ministry of Health and
Welfare; Ministry of Education, Science, Sports and Culture; the Naito
Foundation; and the Health Science Foundation, Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. Phone:
81-3-3202-7181, ext. 2833. Fax: 81-3-3205-1236. E-mail:
mmatsuda{at}ri.imcj.go.jp.
 |
REFERENCES |
| 1.
|
Altschuler, D. L., and F. Ribeiro-Neto.
1998.
Mitogenic and oncogenic properties of the small G protein Rap1b.
Proc. Natl. Acad. Sci. USA
95:7475-7479[Abstract/Free Full Text].
|
| 2.
|
Beranger, F.,
B. Goud,
A. Tavitian, and J. de Gunzburg.
1991.
Association of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgi complex.
Proc. Natl. Acad. Sci. USA
88:1606-1610[Abstract/Free Full Text].
|
| 3.
|
Beranger, F.,
A. Tavitian, and J. de Gunzburg.
1991.
Post-translational processing and subcellular localization of the Ras-related Rap2 protein.
Oncogene
6:1835-1842[Medline].
|
| 4.
|
Bos, J. L.
1998.
All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral.
EMBO J.
17:6776-6782[CrossRef][Medline].
|
| 5.
|
Bos, J. L.
1997.
Ras-like GTPases.
Biochim. Biophys. Acta
1333:M19-M31[Medline].
|
| 6.
|
Bos, J. L.,
B. Franke,
L. M'Rabet,
K. Reedquist, and F. Zwartkruis.
1997.
In search of a function for the Ras-like GTPase Rap1.
FEBS Lett.
410:59-62[CrossRef][Medline].
|
| 7.
|
Boussiotis, V. A.,
G. J. Freeman,
A. Berezovskaya,
D. L. Barber, and L. M. Nadler.
1997.
Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1.
Science
278:124-128[Abstract/Free Full Text].
|
| 8.
|
Campbell, S. L.,
R. Khosravi-Far,
K. L. Rossman,
G. J. Clark, and C. J. Der.
1998.
Increasing complexity of Ras signaling.
Oncogene
17:1395-1413[CrossRef][Medline].
|
| 9.
|
Choy, E.,
V. K. Chiu,
J. Silletti,
M. Feoktistov,
T. Morimoto,
D. Michaelson,
I. E. Ivanov, and M. R. Philips.
1999.
Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi.
Cell
98:69-80[CrossRef][Medline].
|
| 10.
|
Cook, S. J.,
B. Rubinfeld,
I. Albert, and F. McCormick.
1993.
RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts.
EMBO J.
12:3475-3485[Medline].
|
| 11.
|
de Rooij, J.,
N. M. Boenink,
M. van Triest,
R. H. Cool,
A. Wittinghofer, and J. L. Bos.
1999.
PDZ-GEF1, a guanine nucleotide exchange factor specific for Rap1 and Rap2.
J. Biol. Chem.
274:38125-38130[Abstract/Free Full Text].
|
| 12.
|
de Rooij, J.,
F. J. Zwartkruis,
M. H. Verheijen,
R. H. Cool,
S. M. Nijman,
A. Wittinghofer, and J. L. Bos.
1998.
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP.
Nature
396:474-477[CrossRef][Medline].
|
| 13.
|
Foster, R.,
K.-Q. Hu,
Y. Lu,
K. M. Nolan,
J. Thissen, and J. Settleman.
1996.
Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation.
Mol. Cell. Biol.
16:2689-2699[Abstract].
|
| 14.
|
Franke, B.,
J. W. Akkerman, and J. L. Bos.
1997.
Rapid Ca2+-mediated activation of Rap1 in human platelets.
EMBO J.
16:252-259[CrossRef][Medline].
|
| 15.
|
Gotoh, T.,
S. Hattori,
S. Nakamura,
H. Kitayama,
M. Noda,
Y. Takai,
K. Kaibuchi,
H. Matsui,
O. Hatase,
H. Takahashi,
T. Kurata, and M. Matsuda.
1995.
Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G.
Mol. Cell. Biol.
15:6746-6753[Abstract].
|
| 16.
|
Gotoh, T.,
Y. Niino,
M. Tokuda,
O. Hatase,
S. Nakamura,
M. Matsuda, and S. Hattori.
1997.
Activation of R-Ras by Ras-guanine nucleotide-releasing factor.
J. Biol. Chem.
272:18602-18607[Abstract/Free Full Text].
|
| 17.
|
Guasch, R. M.,
P. Scambler,
G. E. Jones, and A. J. Ridley.
1998.
RhoE regulates actin cytoskeleton organization and cell migration.
Mol. Cell. Biol.
18:4761-4771[Abstract/Free Full Text].
|
| 18.
|
Hattori, S.,
M. Maekawa, and S. Nakamura.
1992.
Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
Oncogene
7:481-485[Medline].
|
| 19.
|
Hu, C. D.,
K. Kariya,
G. Kotani,
M. Shirouzu,
S. Yokoyama, and T. Kataoka.
1997.
Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1.
J. Biol. Chem.
272:11702-11705[Abstract/Free Full Text].
|
| 20.
|
Hu, C. D.,
K. Kariya,
M. Tamada,
K. Akasaka,
M. Shirouzu,
S. Yokoyama, and T. Kataoka.
1995.
Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras.
J. Biol. Chem.
270:30274-30277[Abstract/Free Full Text].
|
| 21.
|
Janoueix-Lerosey, I.,
E. Pasheva,
M. F. de Tand,
A. Tavitian, and J. de Gunzburg.
1998.
Identification of a specific effector of the small GTP-binding protein Rap2.
Eur. J. Biochem.
252:290-298[Medline].
|
| 22.
|
Janoueix-Lerosey, I.,
P. Polakis,
A. Tavitian, and J. de Gunzburg.
1992.
Regulation of the GTPase activity of the ras-related rap2 protein.
Biochem. Biophys. Res. Commun.
189:455-464[CrossRef][Medline].
|
| 23.
|
Jimenez, B.,
V. Pizon,
I. Lerosey,
F. Beranger,
A. Tavitian, and J. de Gunzburg.
1991.
Effects of the ras-related rap2 protein on cellular proliferation.
Int. J. Cancer
49:471-479[Medline].
|
| 24.
|
Kanai, T.,
S. Hirohashi,
M. Noguchi,
Y. Shimoyama,
Y. Shimosato,
S. Noguchi,
S. Nishimura, and O. Abe.
1987.
Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis.
Jpn. J. Cancer Res.
78:1314-1318[Medline].
|
| 25.
|
Katagiri, K.,
M. Hattori,
N. Minato,
S.-K. Irie,
K. Takatsu, and T. Kinashi.
2000.
Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase.
Mol. Cell. Biol.
20:1956-1969[Abstract/Free Full Text].
|
| 26.
|
Kawai, S.
1980.
Transformation of rat cells by fusion-infection with Rous sarcoma virus.
J. Virol.
34:772-776[Abstract/Free Full Text].
|
| 27.
|
Kawasaki, H.,
G. M. Springett,
N. Mochizuki,
S. Toki,
M. Nakaya,
M. Matsuda,
D. E. Housman, and A. M. Graybiel.
1998.
A family of cAMP-binding proteins that directly activate Rap1.
Science
282:2275-2279[Abstract/Free Full Text].
|
| 28.
|
Kawasaki, H.,
G. M. Springett,
S. Toki,
J. J. Canales,
P. Harlan,
J. P. Blumenstiel,
E. J. Chen,
I. A. Bany,
N. Mochizuki,
A. Ashbacher,
M. Matsuda,
D. E. Housman, and A. M. Graybiel.
1998.
A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia.
Proc. Natl. Acad. Sci. USA
95:13278-13283[Abstract/Free Full Text]. (Erratum 96:318, 1999.)
|
| 29.
|
Kaziro, Y.,
H. Itoh,
T. Kozasa,
M. Nakafuku, and T. Satoh.
1991.
Structure and function of signal-transducing GTP-binding proteins.
Annu. Rev. Biochem.
60:349-400[CrossRef][Medline].
|
| 30.
|
Kitayama, H.,
Y. Sugimoto,
T. Matsuzaki,
Y. Ikawa, and M. Noda.
1989.
A ras-related gene with transformation suppressor activity.
Cell
56:77-84[CrossRef][Medline].
|
| 31.
|
Kurachi, H.,
Y. Wada,
N. Tsukamoto,
M. Maeda,
H. Kubota,
M. Hattori,
K. Iwai, and N. Minato.
1997.
Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product.
J. Biol. Chem.
272:28081-28088[Abstract/Free Full Text].
|
| 32.
|
Lenzen, C.,
R. H. Cool, and A. Wittinghofer.
1995.
Analysis of intrinsic and CDC25-stimulated guanine nucleotide exchange of p21ras-nucleotide complexes by fluorescence measurements.
Methods Enzymol.
255:95-109[Medline].
|
| 33.
|
Matsubara, K.,
S. Kishida,
Y. Matsuura,
H. Kitayama,
M. Noda, and A. Kikuchi.
1999.
Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation.
Oncogene
18:1303-1312[CrossRef][Medline].
|
| 34.
|
Matsuda, M.,
B. J. Mayer,
Y. Fukui, and H. Hanafusa.
1990.
Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.
Science
248:1537-1539[Abstract/Free Full Text].
|
| 35.
|
Matsuda, M.,
S. Tanaka,
S. Nagata,
A. Kojima,
T. Kurata, and M. Shibuya.
1992.
Two species of human CRK cDNA encode proteins with distinct biological activities.
Mol. Cell. Biol.
12:3482-3489[Abstract/Free Full Text].
|
| 36.
|
Mayer, B. J.,
R. Jove,
J. F. Krane,
F. Poirier,
G. Calothy, and H. Hanafusa.
1986.
Genetic lesions involved in temperature sensitivity of the src gene products of four Rous sarcoma virus mutants.
J. Virol.
60:858-867[Abstract/Free Full Text].
|
| 37.
|
Mochizuki, N.,
Y. Ohba,
E. Kiyokawa,
T. Kurata,
T. Murakami,
T. Ozaki,
A. Kitabatake,
K. Nagashima, and M. Matsuda.
1999.
Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i).
Nature
400:891-894[CrossRef][Medline].
|
| 38.
|
Nancy, V.,
R. M. Wolthuis,
M. F. de Tand,
I. Janoueix-Lerosey,
J. L. Bos, and J. de Gunzburg.
1999.
Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2.
J. Biol. Chem.
274:8737-8745[Abstract/Free Full Text].
|
| 39.
|
Niwa, H.,
K. Yamamura, and J. Miyazaki.
1991.
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
Gene
108:193-199[CrossRef][Medline].
|
| 40.
|
Okada, S.,
M. Matsuda,
M. Anafi,
T. Pawson, and J. E. Pessin.
1998.
Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes.
EMBO J.
17:2554-2565[CrossRef][Medline].
|
| 41.
|
Okada, T.,
C.-D. Hu,
T.-G. Jin,
K.-I. Kariya,
Y. Yamawaki-Kataoka, and T. Kataoka.
1999.
The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases.
Mol. Cell. Biol.
19:6057-6064[Abstract/Free Full Text].
|
| 42.
|
Panayotou, G.,
G. Gish,
P. End,
O. Truong,
I. Gout,
R. Dhand,
M. J. Fry,
I. Hiles,
T. Pawson, and M. D. Waterfield.
1993.
Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor -receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach.
Mol. Cell. Biol.
13:3567-3576[Abstract/Free Full Text].
|
| 43.
|
Posern, G.,
C. K. Weber,
U. R. Rapp, and S. M. Feller.
1998.
Activity of Rap1 is regulated by bombesin, cell adhesion, and cell density in NIH3T3 fibroblasts.
J. Biol. Chem.
273:24297-24300[Abstract/Free Full Text].
|
| 44.
|
Reedquist, K. A., and J. L. Bos.
1998.
Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes.
J. Biol. Chem.
273:4944-4949[Abstract/Free Full Text].
|
| 45.
|
Reedquist, K. A.,
E. Ross,
E. A. Koop,
R. M. Wolthuis,
F. J. Zwartkruis,
Y. van Kooyk,
M. Salmon,
C. D. Buckley, and J. L. Bos.
2000.
The small GTPase, rap1, mediates CD31-induced integrin adhesion.
J. Cell Biol.
148:1151-1158[Abstract/Free Full Text].
|
| 46.
|
Roth, J.
1989.
Postembedding labeling on Lowicryl K4M tissue sections: detection and modification of cellular components.
Methods Cell Biol.
31:513-551[Medline].
|
| 47.
|
Sakoda, T.,
K. Kaibuchi,
K. Kishi,
S. Kishida,
K. Doi,
M. Hoshino,
S. Hattori, and Y. Takai.
1992.
smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
Oncogene
7:1705-1711[Medline].
|
| 48.
|
Satoh, T.,
Y. Uehara, and Y. Kaziro.
1992.
Inhibition of interleukin 3 and granulocyte-macrophage colony-stimulating factor stimulated increase of active ras. GTP by herbimycin A, a specific inhibitor of tyrosine kinases.
J. Biol. Chem.
267:2537-2541[Abstract/Free Full Text].
|
| 49.
|
Tanaka, M.,
R. Gupta, and B. J. Mayer.
1995.
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Mol. Cell. Biol.
15:6829-6837[Abstract].
|
| 50.
|
Tanaka, S.,
T. Morishita,
Y. Hashimoto,
S. Hattori,
S. Nakamura,
M. Shibuya,
K. Matuoka,
T. Takenawa,
T. Kurata,
K. Nagashima, and M. Matsuda.
1994.
C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins.
Proc. Natl. Acad. Sci. USA
91:3443-3447[Abstract/Free Full Text].
|
| 51.
|
van den Berghe, N.,
R. H. Cool,
G. Horn, and A. Wittinghofer.
1997.
Biochemical characterization of C3G: an exchange factor that discriminates between Rap1 and Rap2 and is not inhibited by Rap1A(S17N).
Oncogene
15:845-850[CrossRef][Medline].
|
| 52.
|
Vossler, M. R.,
H. Yao,
R. D. York,
M. G. Pan,
C. S. Rim, and P. J. Stork.
1997.
cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.
Cell
89:73-82[CrossRef][Medline].
|
| 53.
|
Yatani, A.,
L. A. Quilliam,
A. M. Brown, and G. M. Bokoch.
1991.
Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K+ channels.
J. Biol. Chem.
266:22872-22877[Abstract/Free Full Text].
|
| 54.
|
York, R. D.,
H. Yao,
T. Dillon,
C. L. Ellig,
S. P. Eckert,
E. W. McCleskey, and P. J. Stork.
1998.
Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
Nature
392:622-626[CrossRef][Medline].
|
| 55.
|
Yoshida, Y.,
M. Kawata,
Y. Miura,
T. Musha,
T. Sasaki,
A. Kikuchi, and Y. Takai.
1992.
Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes.
Mol. Cell. Biol.
12:3407-3414[Abstract/Free Full Text].
|
| 56.
|
Zhang, K.,
M. Noda,
W. C. Vass,
A. G. Papageorge, and D. R. Lowy.
1990.
Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.
Science
249:162-165[Abstract/Free Full Text].
|
Molecular and Cellular Biology, August 2000, p. 6074-6083, Vol. 20, No. 16
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tse, K. W. K., Dang-Lawson, M., Lee, R. L., Vong, D., Bulic, A., Buckbinder, L., Gold, M. R.
(2009). B Cell Receptor-induced Phosphorylation of Pyk2 and Focal Adhesion Kinase Involves Integrins and the Rap GTPases and Is Required for B Cell Spreading. J. Biol. Chem.
284: 22865-22877
[Abstract]
[Full Text]
-
Borland, G., Bird, R. J., Palmer, T. M., Yarwood, S. J.
(2009). Activation of Protein Kinase C{alpha} by EPAC1 Is Required for the ERK- and CCAAT/Enhancer-binding Protein {beta}-dependent Induction of the SOCS-3 Gene by Cyclic AMP in COS1 Cells. J. Biol. Chem.
284: 17391-17403
[Abstract]
[Full Text]
-
Ponsioen, B., Gloerich, M., Ritsma, L., Rehmann, H., Bos, J. L., Jalink, K.
(2009). Direct Spatial Control of Epac1 by Cyclic AMP. Mol. Cell. Biol.
29: 2521-2531
[Abstract]
[Full Text]
-
Ryu, J., Futai, K., Feliu, M., Weinberg, R., Sheng, M.
(2008). Constitutively Active Rap2 Transgenic Mice Display Fewer Dendritic Spines, Reduced Extracellular Signal-Regulated Kinase Signaling, Enhanced Long-Term Depression, and Impaired Spatial Learning and Fear Extinction. J. Neurosci.
28: 8178-8188
[Abstract]
[Full Text]
-
Richter, M., Murai, K. K., Bourgin, C., Pak, D. T., Pasquale, E. B.
(2007). The EphA4 Receptor Regulates Neuronal Morphology through SPAR-Mediated Inactivation of Rap GTPases. J. Neurosci.
27: 14205-14215
[Abstract]
[Full Text]
-
Li, Y., Yan, J., De, P., Chang, H.-C., Yamauchi, A., Christopherson, K. W. II, Paranavitana, N. C., Peng, X., Kim, C., Munugulavadla, V., Kapur, R., Chen, H., Shou, W., Stone, J. C., Kaplan, M. H., Dinauer, M. C., Durden, D. L., Quilliam, L. A.
(2007). Rap1a Null Mice Have Altered Myeloid Cell Functions Suggesting Distinct Roles for the Closely Related Rap1a and 1b Proteins. J. Immunol.
179: 8322-8331
[Abstract]
[Full Text]
-
Miertzschke, M., Stanley, P., Bunney, T. D., Rodrigues-Lima, F., Hogg, N., Katan, M.
(2007). Characterization of Interactions of Adapter Protein RAPL/Nore1B with RAP GTPases and Their Role in T Cell Migration. J. Biol. Chem.
282: 30629-30642
[Abstract]
[Full Text]
-
Kuijpers, T. W., Bruggen, R. v., Kamerbeek, N., Tool, A. T. J., Hicsonmez, G., Gurgey, A., Karow, A., Verhoeven, A. J., Seeger, K., Sanal, O., Niemeyer, C., Roos, D.
(2007). Natural history and early diagnosis of LAD-1/variant syndrome. Blood
109: 3529-3537
[Abstract]
[Full Text]
-
Kukimoto-Niino, M., Takagi, T., Akasaka, R., Murayama, K., Uchikubo-Kamo, T., Terada, T., Inoue, M., Watanabe, S., Tanaka, A., Hayashizaki, Y., Kigawa, T., Shirouzu, M., Yokoyama, S.
(2006). Crystal Structure of the RUN Domain of the RAP2-interacting Protein x. J. Biol. Chem.
281: 31843-31853
[Abstract]
[Full Text]
-
Duchniewicz, M., Zemojtel, T., Kolanczyk, M., Grossmann, S., Scheele, J. S., Zwartkruis, F. J. T.
(2006). Rap1A-Deficient T and B Cells Show Impaired Integrin-Mediated Cell Adhesion. Mol. Cell. Biol.
26: 643-653
[Abstract]
[Full Text]
-
Murakami, Y., Siripanyaphinyo, U., Hong, Y., Tashima, Y., Maeda, Y., Kinoshita, T.
(2005). The Initial Enzyme for Glycosylphosphatidylinositol Biosynthesis Requires PIG-Y, a Seventh Component. Mol. Biol. Cell
16: 5236-5246
[Abstract]
[Full Text]
-
Chotani, M. A., Mitra, S., Eid, A. H., Han, S. A., Flavahan, N. A.
(2005). Distinct cAMP signaling pathways differentially regulate {alpha}2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol.
288: H69-H76
[Abstract]
[Full Text]
-
Taira, K., Umikawa, M., Takei, K., Myagmar, B.-E., Shinzato, M., Machida, N., Uezato, H., Nonaka, S., Kariya, K.-i.
(2004). The Traf2- and Nck-interacting Kinase as a Putative Effector of Rap2 to Regulate Actin Cytoskeleton. J. Biol. Chem.
279: 49488-49496
[Abstract]
[Full Text]
-
Dail, M., Kalo, M. S., Seddon, J. A., Cote, J.-F., Vuori, K., Pasquale, E. B.
(2004). SHEP1 Function in Cell Migration Is Impaired by a Single Amino Acid Mutation That Disrupts Association with the Scaffolding Protein Cas but Not with Ras GTPases. J. Biol. Chem.
279: 41892-41902
[Abstract]
[Full Text]
-
Stope, M. B., vom Dorp, F., Szatkowski, D., Bohm, A., Keiper, M., Nolte, J., Oude Weernink, P. A., Rosskopf, D., Evellin, S., Jakobs, K. H., Schmidt, M.
(2004). Rap2B-Dependent Stimulation of Phospholipase C-{varepsilon} by Epidermal Growth Factor Receptor Mediated by c-Src Phosphorylation of RasGRP3. Mol. Cell. Biol.
24: 4664-4676
[Abstract]
[Full Text]
-
Takaya, A., Ohba, Y., Kurokawa, K., Matsuda, M.
(2004). RalA Activation at Nascent Lamellipodia of Epidermal Growth Factor-stimulated Cos7 Cells and Migrating Madin-Darby Canine Kidney Cells. Mol. Biol. Cell
15: 2549-2557
[Abstract]
[Full Text]
-
Shivakrupa, R., Radha, V., Sudhakar, Ch., Swarup, G.
(2003). Physical and Functional Interaction between Hck Tyrosine Kinase and Guanine Nucleotide Exchange Factor C3G Results in Apoptosis, Which Is Independent of C3G Catalytic Domain. J. Biol. Chem.
278: 52188-52194
[Abstract]
[Full Text]
-
Christian, S. L., Lee, R. L., McLeod, S. J., Burgess, A. E., Li, A. H. Y., Dang-Lawson, M., Lin, K. B. L., Gold, M. R.
(2003). Activation of the Rap GTPases in B Lymphocytes Modulates B Cell Antigen Receptor-induced Activation of Akt but Has No Effect on MAPK Activation. J. Biol. Chem.
278: 41756-41767
[Abstract]
[Full Text]
-
Ling, L., Zhu, T., Lobie, P. E.
(2003). Src-CrkII-C3G-dependent Activation of Rap1 Switches Growth Hormone-stimulated p44/42 MAP Kinase and JNK/SAPK Activities. J. Biol. Chem.
278: 27301-27311
[Abstract]
[Full Text]
-
Sakakibara, A., Ohba, Y., Kurokawa, K., Matsuda, M., Hattori, S.
(2003). Novel function of Chat in controlling cell adhesion via Cas-Crk-C3G-pathway-mediated Rap1 activation. J. Cell Sci.
115: 4915-4924
[Abstract]
[Full Text]
-
Singh, L., Gao, Q., Kumar, A., Gotoh, T., Wazer, D. E., Band, H., Feig, L. A., Band, V.
(2002). The High-Risk Human Papillomavirus Type 16 E6 Counters the GAP Function of E6TP1 toward Small Rap G Proteins. J. Virol.
77: 1614-1620
[Abstract]
[Full Text]
-
Kontani, K., Tada, M., Ogawa, T., Okai, T., Saito, K., Araki, Y., Katada, T.
(2002). Di-Ras, a Distinct Subgroup of Ras Family GTPases with Unique Biochemical Properties. J. Biol. Chem.
277: 41070-41078
[Abstract]
[Full Text]
-
Itoh, R. E., Kurokawa, K., Ohba, Y., Yoshizaki, H., Mochizuki, N., Matsuda, M.
(2002). Activation of Rac and Cdc42 Video Imaged by Fluorescent Resonance Energy Transfer-Based Single-Molecule Probes in the Membrane of Living Cells. Mol. Cell. Biol.
22: 6582-6591
[Abstract]
[Full Text]
-
McLeod, S. J., Li, A. H. Y., Lee, R. L., Burgess, A. E., Gold, M. R.
(2002). The Rap GTPases Regulate B Cell Migration Toward the Chemokine Stromal Cell-Derived Factor-1 (CXCL12): Potential Role for Rap2 in Promoting B Cell Migration. J. Immunol.
169: 1365-1371
[Abstract]
[Full Text]
-
Jin, T.-G., Satoh, T., Liao, Y., Song, C., Gao, X., Kariya, K.-i., Hu, C.-D., Kataoka, T.
(2001). Role of the CDC25 Homology Domain of Phospholipase Cepsilon in Amplification of Rap1-dependent Signaling. J. Biol. Chem.
276: 30301-30307
[Abstract]
[Full Text]